-
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
24 Apr 2024 20:51 GMT
… -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on … a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because … company’s common stock. Nasdaq indicated that the Company … in patients by the FDA. Such approval, if granted, could …
-
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
24 Apr 2024 18:00 GMT
… -- Amarin Corporation plc (NASDAQ:AMRN) today announced its … Food and Drug Administration (FDA) requesting that the Commissioner … health, requests that the FDA require revised labelling for … FDA, NDA 22224/S-011, Trilipix (fenofibric acid) Approval …
-
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
24 Apr 2024 15:52 GMT
… clinical study required for FDA approval
AVERSA Fentanyl being … #47; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged … following development milestones:
FDA Pre-IND Meeting
Pivotal … Manipulation and Extraction Study
FDA IND Filing
Pivotal …
-
Capricor Announces Positive Type-B Interaction With FDA For CAP-1002 In Treating DMD
24 Apr 2024 15:15 GMT
… dystrophy or DMD.
Currently, the shares are at $5.22, up … volume of 551,936.
The FDA advised Capricor to include a … safety and efficacy data with FDA.
Data from Cohort B of … will not be necessary for FDA approval of the product.
CAP-1002 …
-
GSK's endometrial cancer drug receives FDA approval
24 Apr 2024 14:46 GMT
GSK said the FDA had given the green light … /microsatellite stable tumours.
The approval was based on results from … .
As of 0920 BST, GSK shares were up 0.35% at …
-
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
24 Apr 2024 14:31 GMT
… shortly — or getting the initial approval in the coming period. Moving … the queue? See also 10 Stocks You Should Not Buy According … Session Follow Novartis A G (NYSE:NVS) Follow Novartis A G … pending at the FDA on the basis for approval and also the …
-
Danaher Corporation (NYSE:DHR) Q1 2024 Earnings Call Transcript
24 Apr 2024 14:28 GMT
… setback, the number of new FDA approvals for biologic (ph) and … pathology slide scanner recently received FDA 510(k) clearance. Now … January, Cepheid received expanded FDA clearance with a CLIA waiver … Danaher Corp (NYSE:DHR) Follow Danaher Corp (NYSE:DHR) We …
-
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
24 Apr 2024 13:00 GMT
… NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company … dystrophy (“DMD”). The FDA has affirmed alignment with … not be necessary for FDA approval of the product.
… Therapeutics Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology …
-
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
24 Apr 2024 13:21 GMT
… Since ARCALYST approval as the first and only FDA approved drug … disease currently with no FDA approved therapies. Second, … 15 Best Affordable Dividend Stocks To Invest In Right … Follow Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) Follow Kiniksa Pharmaceuticals …
-
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
24 Apr 2024 12:28 GMT
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or … approval from the U.S. Food and Drug Administration (“FDA”). …
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater … and Drug Administration product approval requirements; the impact …